Peer Review History

Original SubmissionApril 1, 2025
Decision Letter - Guadalupe Nevárez-Moorillón, Editor

Dear Dr. Estrada,

Please submit your revised manuscript by Jun 21 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Guadalupe Virginia Nevárez-Moorillón, Ph.D.

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1.  Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf   and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following financial disclosure:

“Consejo Nacional de Humanidades Ciencias y Tecnologías (CONAHCYT) Grant 2020-000013-01NACF-03858”

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

3. Thank you for stating the following in the Acknowledgments Section of your manuscript:

“We thank the Consejo Nacional de Humanidades Ciencias y Tecnologías (CONAHCYT) for the grant 2020-000013-01NACF-03858 awarded to Blanca Nayelli Ocampo Morales. We also thank Jerome Verleyen for his technical support and for granting us access to the HPC infrastructure at the Unidad Universitaria de Secuenciación Masiva y Bioinformática, Instituto de Biotecnología (UNAM), and Mabel Rodríguez for her invaluable assistance with proofreading, and insightful suggestions.”

We note that you have provided funding information that is currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

“Consejo Nacional de Humanidades Ciencias y Tecnologías (CONAHCYT) Grant 2020-000013-01NACF-03858”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

4. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process.

5. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: No

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: No

**********

Reviewer #1: Line 32: maturation

Line 63: Any reason why samples are transported at room temperature? This is not common practice and needs to be explained why it was chosen.

Line 157: Some research, .....

Line 158 - 162: lines have been mixed due to figure legend

I have some concern in relation to the three time points and two pooled replicates that were used for sequencing. Pooling reduces the ability to detect within-group variability. The use of different statistical tests depending on normality is valid, but more detail is needed on how normality was assessed (e.g., K-S test results per variable).

Concerning metagenomic Interpretation the link between microbial changes and physicochemical shifts could be better substantiated (e.g., with correlation matrices or PCA plots).

Species-level claims (e.g., “C. tropicalis increased”) must be cautiously interpreted from ITS data due to potential misclassification or sequencing errors at the species level.

In safety and pathogenicity discussion of Aeromonas, Enterobacter, and Chryseobacterium you should include clearer risk assessments. Are these levels of concern? Could you relate abundance to CFU/mL equivalents or thresholds?

Consider consistent use of either “ripening” or “maturation” (currently both are used interchangeably).

Last but not least make sure that your data are available.

Reviewer #2: Review of Manuscript PONE-D-25-17545

General Comments:

This manuscript presents a timely and relevant investigation into the microbial and physicochemical dynamics of cheese ripening across multiple sites and time points. The integration of 16S and ITS amplicon sequencing with environmental metadata is commendable and offers the potential for valuable insight into microbial succession in artisanal food production. The subject matter is of clear interest to the fields of microbial ecology, food microbiology, and fermentation science.

However, the study suffers from several critical limitations—chief among them, the pooling of DNA prior to sequencing, which undermines the resolution and statistical reliability of the microbial analyses. In addition, the data visualization, methodological transparency, and statistical interpretation would benefit from significant improvement to fully support the conclusions.

Major Comments:

Pooling of samples prior to sequencing:

The choice to pool DNA samples from biological replicates before amplicon sequencing—while perhaps financially motivated—substantially weakens the inferential power of the study. Without within-group replication, variation among samples cannot be properly assessed, and statistical comparisons (e.g., of alpha or beta diversity) are rendered less meaningful. The authors should explicitly acknowledge this limitation in the manuscript and discuss its implications for interpretation. For context, see Prosser (2010, PLoS ONE, PMID: 20438583 https://pubmed.ncbi.nlm.nih.gov/20438583/), which emphasizes the importance of replication in microbial community profiling.

Microbial data visualization:

The current relative abundance plots and diversity metrics are standard but do not make full use of the richness of the dataset. I recommend generating a comprehensive heatmap where each cell reflects the relative abundance of an ASV in a given sample, combining both 16S and ITS data where possible. Samples can be clustered based on beta diversity distances and annotated with metadata (ripening time, location, microbial load, etc.), and ASVs can be annotated by taxonomy, prevalence, and timepoint distribution. A carefully constructed figure of this kind would significantly enhance the communicative power of the results.

ITS taxonomy and database transparency:

Please specify which version of the UNITE database was used for ITS taxonomy assignment, whether dynamic species hypotheses or clustering thresholds were applied, and what confidence levels were considered acceptable. These parameters are critical for reproducibility and evaluation of fungal identifications.

Reproducibility and data processing:

The manuscript would benefit from more detailed reporting of the bioinformatics pipeline. I recommend reviewing and potentially adapting established workflows such as metabaRpipe for processing mixed 16S/ITS datasets. For downstream ecological analysis and visualization, the authors might consult this well-documented microbiome R tutorial, which could also support better integration of metadata.

Statistical rigor:

The statistical analyses used to compare microbial communities and physicochemical traits across conditions should be clearly described. Were PERMANOVA or other multivariate models used? Were corrections for multiple testing applied? Without sequencing replicates, the scope of valid statistical inference is limited. This caveat should be carefully considered in both the Methods and Discussion sections.

Language and Clarity:

The manuscript is generally understandable, but there are numerous instances of awkward phrasing, grammatical errors, and unclear sentence construction that impede readability. A thorough language revision is strongly recommended. The authors may benefit from using professional English editing services or advanced AI-based tools (e.g., Grammarly, DeepL Write, or ChatGPT-based editing) to polish the language. Doing so would improve the flow, clarity, and overall professional presentation of the manuscript.

Minor Comments:

Some figure labels and axis annotations are low in resolution or difficult to read. Ensure all visuals meet journal-quality standards.

Clarify whether normalization (e.g., rarefaction or compositional data transformation) was performed before diversity analyses.

Maintain consistency in terminology (e.g., use "ASVs" rather than "OTUs," italicize genus/species names, unify abbreviations like "PC1" vs. "PC-1").

Expand the Introduction to more thoroughly situate the study in the context of existing research on cheese microbiota and fermentation ecology.

Conclusion:

This work contributes valuable empirical data to the study of cheese microbial ecology, but its impact is constrained by methodological and presentational limitations. A major revision—addressing statistical robustness, figure clarity, language, and methodological transparency—is needed to ensure the conclusions are well-supported and clearly communicated. I encourage the authors to revise accordingly and would be glad to review a revised version.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

Reviewer #2: Yes:  Florentin Constancias

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Revision 1

Reviewer #1:

# Line 63: Any reason why samples are transported at room temperature? This is not common practice and needs to be explained why it was chosen.

Thank you for this important question regarding our sample transport protocol. To clarify, all samples were transported in an insulated cooler box without ice packs. We refer to this as 'room temperature' transport, as the goal was to protect the samples from abrupt temperature fluctuations rather than to actively cool them.

For our aged and semi-aged samples (T2 and T3), the decision to transport at this controlled ambient temperature was based on the specific matrix of hard, low-water-activity cheese. For these samples, the low water activity (a_w) and low pH act as potent natural preservatives, ensuring the stability of the microbial community DNA during short-term transport.

For the fresh, 2-day-old sample (T1), which has a higher moisture content, we acknowledge that cold transport is a common practice. However, our approach of using an insulated container without active cooling was chosen to better preserve the natural conditions and ongoing microbial dynamics of the very early ripening stage. By avoiding refrigeration, we aimed to capture a snapshot of the community that was not subjected to a sudden cold shock, which could potentially alter the metabolic state and viability of key starter microorganisms.

We believe this strategy was appropriate for the distinct nature of the samples at their different maturational stages. To ensure this is clear to the reader, we have clarified this rationale in the revised manuscript.

# Line 157: Some research, .....

# Line 158 - 162: lines have been mixed due to figure legend

This has been corrected

# I have some concern in relation to the three time points and two pooled replicates that were used for sequencing. Pooling reduces the ability to detect within-group variability. The use of different statistical tests depending on normality is valid, but more detail is needed on how normality was assessed (e.g., K-S test results per variable).

We appreciate the reviewer’s valuable suggestion. In response, the Kolmogorov-Smirnov test was performed for each treatment group to assess normality. The Kolmogorov-Smirnov normality test was applied using the MINITAB 2017 statistical program (Minitab, LLC, Pine Hall Road, PA, USA).

Table 1 shows that all variables follow a normal distribution at the three maturation times, except for T3 for fungi and yeasts.

Table 1. Values of the Kolmogorov-Smirnov normality test probability by variable. (Table details in our Response to Reviewers document)

A p-value greater than 0.05 indicates that the data follow a normal distribution.

# Concerning metagenomic Interpretation the link between microbial changes and physicochemical shifts could be better substantiated (e.g., with correlation matrices or PCA plots).

Principal component analysis was performed using the free software PAST v 5.2.1 (LCC, Oslo, USA) and samples were grouped using k-means. On the other hand, the 3D visualization of the samples was done in Plotly Chart Studio, a free online program (LCC, Montreal, Canada).

In Fig. 2a, the principal component (PC) biplot graph shows that PC1 is 55.79% and PC2 represents 34.11% of the total variance, together explaining 89.90%, which indicates that it is a good model as it requires few explanatory variables. The ripening times are distributed across different quadrants. However, there is a proximity between T1 and T2, as they have similar characteristics.

Fig. 2b shows that T1 can be differentiated by protein content and T2 by moisture and fat. The amount of protein has the highest value in T1 with a value of 27.81% and also contributes positively to the separation of the samples in the biplot-PCA.

The variables humidity and fat did not show any statistical difference, but they had a greater positive contribution in T2. This behavior is explained by the nature of ANOVA, which compares the variability between groups and that within groups (10.5395/rde.2014.39.1.74). On the other hand, the principal components are used to reduce the dimensionality of a data set, and the greatest variance is found in PC1 (https://doi.org/10.1026/j.apacoust.2012.04.012). Finally, the samples belonging to T3 have different physicochemical characteristics than T1 and T2.

(Figures details in our Response to Reviewers document)

Fig 2. a) Score graph of principal component analysis (PCA) grouped with K-means; b) Biplot graph obtained from PCA; c) Bar charts of PCA model loadings for CP1; and d) Bar charts of PCA model loadings for CP2.

# Species-level claims (e.g., “C. tropicalis increased”) must be cautiously interpreted from ITS data due to potential misclassification or sequencing errors at the species level.

Thanks for the comment, you are absolutely right. Some considerations that should be taken into account in this study include: i) errors in species-level classification due to methodological limitations, as only the 16S or ITS regions were sequenced; greater certainty would have been achieved if whole-genome sequencing had been performed, ii) possible sequencing errors (https://doi.org/10.1016/j.funeco.2023.101274), iii) database updates (DOI: 10.3389/fbinf.2024.1278228). These points have already been addressed in the revised manuscript.

# In safety and pathogenicity discussion of Aeromonas, Enterobacter, and Chryseobacterium you should include clearer risk assessments. Are these levels of concern? Could you relate abundance to CFU/mL equivalents or thresholds?

We agree with the reviewer on the importance of assessing the risk associated with these genera. The detection of Aeromonas, Enterobacter, and Chryseobacterium is highlighted as a potential safety concern, as these genera include known opportunistic pathogens and spoilage organisms, even when present at the low relative abundances detected in our study (https://doi.org/10.3390/microorganisms9112377). While this study focused on profiling the microbial community using sequencing and did not include culturing on selective media for quantification (e.g., CFU/mL), the presence of these taxa is a significant finding that warrants attention.

# Consider consistent use of either “ripening” or “maturation” (currently both are used interchangeably).

Last but not least make sure that your data are available.

All sequencing data have been deposited in the NCBI BioProject database under accession number PRJNA1247530, with SRA experiment accessions SRX28272105-SRX28272110.

Reviewer #2: Review of Manuscript PONE-D-25-17545

# Major Comments:

# Pooling of samples prior to sequencing:

The choice to pool DNA samples from biological replicates before amplicon sequencing—while perhaps financially motivated—substantially weakens the inferential power of the study. Without within-group replication, variation among samples cannot be properly assessed, and statistical comparisons (e.g., of alpha or beta diversity) are rendered less meaningful. The authors should explicitly acknowledge this limitation in the manuscript and discuss its implications for interpretation. For context, see Prosser (2010, PLoS ONE, PMID: 20438583 https://pubmed.ncbi.nlm.nih.gov/20438583/), which emphasizes the importance of replication in microbial community profiling.

We thank the reviewer for this important comment. We acknowledge that pooling DNA from biological replicates limits the statistical assessment of within-group variation, and we have explicitly addressed this limitation in the discussion section of our manuscript:

We acknowledge that while this approach does not prevent the calculation of diversity metrics, it significantly impacts the statistical confidence of the resulting comparisons. Specifically, the absence of within-group replicates substantially weakens the statistical power required for a robust beta diversity analysis. Consequently, to ensure our conclusions remained grounded in statistically defensible data, we chose to limit our diversity analysis to alpha diversity metrics. These can still provide valuable insights into the richness and evenness within each representative pooled sample….

The decision to pool was a deliberate methodological choice aimed at obtaining a comprehensive and representative microbial profile for each condition by averaging out inter-sample variability and enhancing the detection of low-abundance taxa.

# Microbial data visualization:

# The current relative abundance plots and diversity metrics are standard but do not make full use of the richness of the dataset. I recommend generating a comprehensive heatmap where each cell reflects the relative abundance of an ASV in a given sample, combining both 16S and ITS data where possible. Samples can be clustered based on beta diversity distances and annotated with metadata (ripening time, location, microbial load, etc.), and ASVs can be annotated by taxonomy, prevalence, and timepoint distribution. A carefully constructed figure of this kind would significantly enhance the communicative power of the results.

We are grateful to the reviewer for this insightful suggestion. We agree that a comprehensive heatmap significantly enhances the visualization of our dataset, and we have incorporated this as a new figure (Fig. 7) in the revised manuscript. This addition has substantially strengthened our results, providing a clearer and more detailed view of the microbial dynamics.

A key feature of this new figure is that it integrates data from both kingdoms, presenting a merged profile of bacterial (16S) and fungal (ITS) genera for each sample. As the reviewer anticipated, the new figure clearly illustrates a distinct ecological succession. The microbial community composition at T1 (2 days) is markedly different from the communities at later ripening stages, T2 (29 days) and T3 (58 days).

To provide a multi-layered view, the figure integrates several components:

Heatmap Core: The central heatmap displays the row-normalized relative abundance (Z-score) of each ASV (rows) across our samples (columns: T1, T2, T3), allowing for a direct comparison of microbial abundance patterns.

Sample Clustering Dendrogram (Top): Samples are clustered using Bray-Curtis dissimilarity, and the resulting dendrogram is displayed above the heatmap. This visually groups the samples based on their overall community similarity, clearly separating the early time point from the later ones.

Taxa Clustering Dendrogram (Left): A dendrogram to the left of the heatmap clusters ASVs based on their abundance profiles, grouping microbes that exhibit similar dynamics across the ripening process.

Metadata Annotation Bars: We have further annotated the sample columns with metadata bars indicating the ripening time, protein content, and the Shannon diversity index for each sample, allowing for the direct visual correlation of these factors with the microbial community structure.

We believe this new, integrated figure directly addresses the reviewer's points and makes the patterns of microbial succession in our study more intuitive and impactful.

Fig. 7. Venn diagram showing the number of specific and common ASVs (ASV 30) between three ripening times of Queso Crema de Chiapas raw cow's milk (2, 29 and 58 d).

(Figures details in our Response to Reviewers document)

# ITS taxonomy and database transparency:

# Please specify which version of the UNITE database was used for ITS taxonomy assignment, whether dynamic species hypotheses or clustering thresholds were applied, and what confidence levels were considered acceptable. These parameters are critical for reproducibility and evaluation of fungal identifications.

We thank the reviewer for this important question. To enhance the clarity and reproducibility of our methods, we have revised the manuscript to include the specific parameters used for taxonomic assignment. The updated text is as follows:

For fungal identification, the taxonomic assignment of ITS sequences was performed using the UNITE database v8.2 (release: 2020-02-04). Amplicon Sequence Variants (ASVs) were defined with a 99% sequence similarity threshold, and assignments were retained only if they met a minimum confidence level of 0.80, the software's default setting.

# Reproducibility and data processing:

# The manuscript would benefit from more detailed reporting of the bioinformatics pipeline. I recommend reviewing and potentially adapting established workflows such as metabaRpipe for processing mixed 16S/ITS datasets. For downstream ecological analysis and visualization, the authors might consult this well-documented microbiome R tutorial, which could also support better integration of metadata.

We are very grateful to the reviewer for their constructive feedback and for bringing the metabaRpipe workflow to our attention. We agree that detailed reporting of the bioinformatics pipeline is paramount for reproducibility. In response, we have expanded the Methods section of our manuscript to provide a comprehensive, step-by-step description of our data processing and analysis protocol.

Our established workflow was carefully designed to ensure high fidelity and is built upon a series of well-vetted, specialized tools that are standard in the field. The process began with a rigorous quality control (QC) of the raw sequencing data, for which we utilized FastQC for quality assessment and Trimmomatic for trimming and filtering, followed by merging of forward (R1) and reverse (R2) reads with FLASH (v1.2.11) to reconstruct full-length amplicon fragments. This initial stage, which is conceptually equivalent to the QC and merging steps in pipelines like metabaRpipe, ensures that only high-quality, complete sequences proceed to the next steps.

Following the merging process, the sequences underwent critical filtering using VSEARCH to first dereplicate the dataset into a set of unique sequences and then to perform de novo chimera detection and removal. This essential step guarantees the integrity of our dataset by eliminating spurious sequences. The resulting high-quality, chimera-free amplicon sequences were then assigned taxonomy using Parallel-Meta (v3.7), a robust tool for high-performance profiling that generated our final abundance and taxonomic tables.

All subsequent statistical and ecological analyses were performed in the R environment, leveraging a suite of powerful and specialized packages to ensure robust and reproducible outcomes. We used the phyloseq package for the core task of integrating the abundance tables, taxonomic data, and sample metadata into a single, cohesive object. Further analysis and visualization were carried out using the microbiome and microbiomeutilities packages. The Venn diagrams, alpha diversity metrics, stacked bar plots with the relative abundance for each amplicon, and integrated heatmap presented in our results were also generated within the R environment.

While we recognize the value of standardized wrappers like metabaRpipe, we are confident that our workflow systematically addresses key stages of metabarcoding analysis, ensuring data quality and reproducibility.

# Statistical rigor:

# The statistical analyses used to compare microbial communities and physicochemical traits across conditions should be clearly described. Were PERMANOVA or other multivariate models used? Were corrections for multiple testing applied? Without sequencing replicates, the scope of valid statistical inference is limited. This caveat should be carefully considered in both the Methods and Discussion sections.

We appreciate the reviewer’s valuable suggestion. In response, a new PCoA analysis has been included, along with the addition of PERMANOVA. The statistical approaches used to compare microbial communities and physicochemical parameters across different conditions are now described in greater detail.

Permutational multivariate analysis of variance (PERMANOVA) was supplemented with principal coordinate analysis (PCoA) and analyzed in PAST v 5.2.1 (LCC, Oslo, USA).

PCoA followed by PERMANOVA based on the Bray-Curtis dissimilarity matrix confirmed the existence of statistically significant differences (p = 0.003) between the physicochemical and microbiological compos

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Guadalupe Nevárez-Moorillón, Editor

Dear Dr. Estrada,

Please submit your revised manuscript by Sep 24 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Guadalupe Virginia Nevárez-Moorillón, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

1. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 

2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: No

**********

Reviewer #1: The issue of sample pooling remains and weakens statistical inference. Pooling biological replicates before sequencing limits assessment of intra-group variability but at the same time is a "common practice" in many published work. The authors acknowledge this, it still affects the depth of beta-diversity analyses and limits robust conclusions.

Also, the identification of fungal species via ITS amplicons (e.g., Candida etchellsii, C. tropicalis) should be interpreted cautiously, and the manuscript does try to do so but verification through culture-based methods or qPCR for critical genera was possible.

The presence of Aeromonas, Enterobacter, and Chryseobacterium is flagged, but quantification (e.g., CFU equivalents or thresholds) is absent. You mention these as “low abundance,” but you do not define what constitutes a risk threshold.

The manuscript has improved compared to previous versions, but there are still grammatical inconsistencies, awkward phrasings, and run-on sentences. A final round of language polishing is strongly advised.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org

Revision 2

Reviewer #1: The issue of sample pooling remains and weakens statistical inference. Pooling biological replicates before sequencing limits assessment of intra-group variability but at the same time is a "common practice" in many published work. The authors acknowledge this, it still affects the depth of beta-diversity analyses and limits robust conclusions.

Also, the identification of fungal species via ITS amplicons (e.g., Candida etchellsii, C. tropicalis) should be interpreted cautiously, and the manuscript does try to do so but verification through culture-based methods or qPCR for critical genera was possible.

The presence of Aeromonas, Enterobacter, and Chryseobacterium is flagged, but quantification (e.g., CFU equivalents or thresholds) is absent. You mention these as “low abundance,” but you do not define what constitutes a risk threshold.

On fungal species identification from ITS amplicons:

We appreciate the reviewer’s caution regarding the taxonomic resolution of ITS-based analyses. Species-level assignments were interpreted conservatively and supported by concurrent qPCR assays targeting Candida etchellsii and C. tropicalis (now explicitly referenced in the revised text, Fig. 8).

qPCR detection (Ct values = 7.22 and 9.84, respectively) confirmed the presence of these species in the corresponding stages (T1 and T3), reinforcing the reliability of the ITS classification.

While full phenotypic validation through culture isolation was beyond the scope of this metagenomic survey, the qPCR results corroborated the taxonomic classification obtained from ITS amplicon sequencing, providing additional confirmation consistent with the sensory and ripening attributes observed in these cheeses.

On low‑abundance genera and absence of quantitative risk thresholds:

We agree that quantitative thresholds enhance risk interpretation. In this study, the potentially pathogenic genera Aeromonas, Enterobacter, and Chryseobacterium were detected at relative abundances < 0.5 % of total reads, which falls below the detection limits commonly associated with microbial spoilage or infection risk in dairy matrices.

Regarding the genera Aeromonas, Enterobacter, and Chryseobacterium, targeted qPCR assays were performed to verify their presence. The amplification curves for Aeromonas and Enterobacter did not cross the fluorescence threshold (Ct > 35), indicating an absence of detectable DNA. Chryseobacterium showed a weak signal (Ct = 3.26 at T2), consistent with a trace or environmental occurrence rather than viable contamination. Together, these findings confirm that the sequences detected by 16S rRNA amplicon analysis likely represent non‑viable or background DNA rather than active populations. Therefore, we maintain that the presence of these genera is not indicative of contamination risk, but rather illustrates the sensitivity of metagenomic surveillance in detecting trace microbial DNA.

Summary clarification added to manuscript

In response to these valuable comments, we have:

Expanded the Materials and Methods section to justify the pooling strategy and reference supporting studies.

Added Ct evidence supporting C. etchellsii and C. tropicalis detection, reinforcing the reliability of ITS identifications.

Quantitatively defined “low abundance” (< 1 % RA) and stated that potentially pathogenic genera were non‑viable under culture conditions.

We thank Reviewer #1 again for these insightful remarks; integrating them has significantly strengthened the methodological transparency and interpretive rigor of this work.

Attachments
Attachment
Submitted filename: Response_to_Reviewers_auresp_2.docx
Decision Letter - Guadalupe Nevárez-Moorillón, Editor

<p>Physicochemical and microbiome changes in queso Crema de Chiapas during ripening

PONE-D-25-17545R2

Dear Dr. Estrada,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support .

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Guadalupe Virginia Nevárez-Moorillón, Ph.D.

Academic Editor

PLOS One

Additional Editor Comments (optional):

Reviewers' comments:

Formally Accepted
Acceptance Letter - Guadalupe Nevárez-Moorillón, Editor

PONE-D-25-17545R2

PLOS One

Dear Dr. Estrada,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Guadalupe Virginia Nevárez-Moorillón

Academic Editor

PLOS One

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .